Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04647916
Recruitment Status : Recruiting
First Posted : December 1, 2020
Last Update Posted : September 22, 2021
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Gilead Sciences
Information provided by (Responsible Party):
Southwest Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 17, 2024
Estimated Study Completion Date : February 2025